| Revenue growth | 2% YoY in Q1 FY27. |
|---|---|
| Margins | EBITDA margin at 27%; PAT margin at 20%. |
| Demand visibility | Strong growth in Specialized Manufacturing (+41% YoY) and Bio-processing (+30%). |
Growth
Revenue +2% YoY to ₹1,898 mn; PAT -5% YoY to ₹386 mn; EBITDA margin at 27%.
Outlook
Focusing on Bio-Catalysis for APIs and expanding Probiotics in human/animal nutrition. Maintaining 400+ proprietary products and 15+ patents.
Risks
Human nutrition segment (-7%) and animal nutrition (-3%) saw YoY de-growth. Sequential EBITDA dropped 19%.
Last quarter's promises, checked
Delivered
- Guided double-digit growth → delivered 17% annual revenue growth (= BEAT)
- Guided steady margins → delivered 31% EBITDA margin (= BEAT)
- Guided R&D center operational H2 FY26 → delivered operational status (= BEAT)
Partly delivered
- Guided EU approval for anti-inflammatory products → dossiers filed, still pending (= PARTIAL)
Missed
- Guided U.S. market growth → delivered 11% revenue decline in INR terms (= MISS)
- Guided Human Nutrition growth → delivered 7% YoY de-growth in Q1 FY27 (= MISS)
- Guided Animal Nutrition growth → delivered 3% YoY de-growth in Q1 FY27 (= MISS)
Investor Presentation filed with NSE, NSE: ADVENZYMES. Summary written with AI assistance from the document.
Advanced Enzyme Technologies Ltd: key numbers
- Share price
- ₹291.15
- Market cap
- ₹3,260 Cr
- Revenue (annual)
- ₹745.8 Cr
- Net profit (annual)
- ₹168.7 Cr
- P/E (TTM)
- 19.6×Sector 50.4×
- Promoter holding
- 43.24%-0.02% QoQ
- FII holding
- 26.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Advanced Enzyme Technologies Ltd
All →Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies Ltd bought back 50,000 equity shares on September 25, 2026. This transaction was executed at an average price of ₹295.80 per share.
- Value
- ₹1.48 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 64,668 shares on September 24, 2026, at an average price of ₹298.0272 per share.
- Value
- ₹1.93 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 63,616 shares at an average price of ₹297.47. The total value of today's buyback transaction is ₹1.89 Crore.
- Value
- ₹1.89 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies Ltd repurchased 1,136 equity shares on September 22, 2026, at an average price of ₹295.90. This daily filing is for compliance.
- Value
- ₹0.03 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 50,000 equity shares on September 21, 2026, at an average price of ₹289.49 per share.
- Value
- ₹1.45 Cr
Advanced Enzyme Technologies Promoter Reclassification
Advanced Enzyme Technologies received requests from four promoter group members to reclassify as 'Public' shareholders. These requests are pending board consideration.